Our studies of rotavirus challenge in adult volunteers enabled us to evaluate the relationship of pre-existing antirotavirus fecal IgA antibody to infection and illness and to investigate the local response to this infection. No relationship could be found between the pre-existing levels of fecal an
Salivary antibody titers in adults challenged with a human rotavirus
✍ Scribed by Dr. Richard L. Ward; Kristine A. Pax; James R. Sherwood; Elizabeth C. Young; Gilbert M. Schiff; David I. Bernstein
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 432 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To determine whether salivary antibody is a reliable indicator of rotavirus infection and mucosal rotavirus antibody concentrations, salivary rotavirus antibody titers were determined as a function of time following inoculation of 24 adult volunteers with a virulent strain of human rotavirus (CJN). Twenty of the subjects became infected and all produced detectable amounts of salivary rotavirus IgA. These antibody concentrations remained undetectable in the four uninfected subjects. Rises of ≥ fourfold in either salivary rotavirus IgA or neutralizing antibody to the challenge virus were detected in all but two subjects. The titers of both antibodies were maximal at 13 days after inoculation and decreased significantly (p < .02) by 27 days, a result very similar to that previously found with stool rotavirus IgA in CJN‐infected subjects. These results suggest that salivary rotavirus antibody titers are an accurate reflection of mucosal rotavirus anti‐body and a possible surrogate for intestinal rotavirus antibody.
📜 SIMILAR VOLUMES
## Abstract Detection of human and bovine rotavirus in stools is described using a double‐antibody sandwich enzyme‐linked immunosorbent assay (ELISA) with polystyrene microtest plates as solid phase, immunoglobulin fraction of rabbit antiserum to rotavirus (human) as catching antibody, and the same
## Abstract Differences in the prevalence of human herpesvirus 8 (HHV‐8) and Kaposi's sarcoma (KS) have been described, depending on the study population and their geographic origin. A cross‐ sectional study aimed at detecting the frequency and titers of antibodies against HHV‐8 latent and lytic an